Tracells Ltd.
Biomed — Stage: R&D. Est: 2023. Tags: Artificial Intelligence, Biotechnology, Cancer, Diagnostics, Life Sciences, MedTech, Non Invasive, Predictive Analytics. Tracells' innovative platform technology advances the diagnosis of Inflammatory Bowel Disease (IBD), as well as offers promising prospects for tackling various gastrointestinal ailments, including celiac disease, colorectal cancer (CRC) and irritable bowel syndrome (IBS). The company technology leverages the human transcriptome of stool samples to accurately diagnose the severity, location and molecular signatures of bowel inflammation.. Web: https://www.tracells.com